We combine our internal expertise with our network of industry and academic sources to provide timely, insightful strategic advice, empowering our clients' success in the complex vaccines and infectious diseases' landscape.

Vaccines remain vital in combating diseases and saving lives. With increased interest in new vaccines, including for COVID-19 and oncology, complexity is rising due to novel assets, partnerships, and technologies.

This necessitates timely, accurate insights so manufacturers and investors can make informed decisions:

For BioPharma clients:

  • Landscape analysis strengthened by expert interviews
  • Market and competitor insights on R&D, clinical development and commercial activities
  • BD&L support

For Investors:

  • Due diligence research
  • New opportunity identification
  • Access to experts’ opinion through a combination of in-house expertise and conduct of bespoke interviews

We also invite you to join our LinkedIn AIDS/HIV Vaccine and Anti-Retrovirals group – a hub for insights on HIV vaccine and other treatments advancements.

Want to better understand and succeed in vaccines? Let’s connect.

Reach out at info@lqventures.com to learn more about our strategic consulting and research capabilities.